C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/25/2004	US20040234553 Cold-adapted equine influenza viruses
11/25/2004	US20040234552 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine
11/25/2004	US20040234551 Use of 3'-utr's from cysteine proteinase genes cpb2 and cpb2.8 of leishmania for directing stage-specific expression
11/25/2004	US20040234549 Novel recombinant and mutant adenoviruses
11/25/2004	US20040234539 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
11/25/2004	US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234521 Antigen detection segments; crosslinking receptors
11/25/2004	US20040234520 Uses for Eph receptor antagonists and agonists
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234517 Prevent gene expression of arginine in metabolism in tissue; arginase inhibitors
11/25/2004	US20040234516 Production of lysosomal enzymes in plants by transient expression
11/25/2004	US20040234512 Method for treating thrombopoiesis and anemia; cytosine phosphate diester guanine; controlling remodeling of immunology system
11/25/2004	US20040234506 Recombinant RSV virus expression systems and vaccines
11/25/2004	US20040234505 Polynucleotide constructs and uses thereof
11/25/2004	US20040234504 Lentiviral vector; nucleic acids; in situ genetic engineering
11/25/2004	US20040234503 Materials and methods relating to improved vaccinations strategies
11/25/2004	US20040234502 Method for treatment of vascular regeneration
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	US20040234472 Micellar drug delivery systems for hydrophobic drugs
11/25/2004	US20040234455 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression
11/25/2004	US20040232205 Lantibiotic
11/25/2004	DE10320259A1 Neuartige Glukose Dehydrogenase und ihre Herstellung Novel glucose dehydrogenase and their preparation
11/25/2004	CA2526935A1 Production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	CA2526911A1 Process of producing a plastid-targeted protein in plant cells
11/25/2004	CA2525912A1 Transcription chip
11/25/2004	CA2525909A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	CA2525870A1 Liver x receptor .alpha. splicing mutant protein, gene thereof and use thereof
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/25/2004	CA2525250A1 Improved methods for protein interaction determination
11/25/2004	CA2525120A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
11/25/2004	CA2525097A1 Plants with increased levels of one or more amino acids
11/25/2004	CA2524499A1 Broadening adenovirus tropism
11/25/2004	CA2524456A1 Apo2l (trail) receptor binding peptides and uses thereof
11/25/2004	CA2523984A1 Improved transformant and process for producing polyester using the same
11/25/2004	CA2523785A1 Small interfering rna libraries and methods of synthesis and use
11/25/2004	CA2523441A1 Functional characterization of myo-inositol monophosphatase
11/25/2004	CA2522692A1 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	CA2522614A1 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
11/24/2004	EP1479781A1 Method for detecting nucleic acids
11/24/2004	EP1479777A1 Method of producing astaxanthin by fermenting selected strains of xanthophyllomyces dendrorhous
11/24/2004	EP1479775A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia
11/24/2004	EP1479774A1 Viruses dependent on inducing agents for viral entry into a host cell
11/24/2004	EP1479773A1 Mite galectin
11/24/2004	EP1479771A2 Method to screen phage display libraries with different ligands
11/24/2004	EP1479770A1 Surface expression libraries of randomized peptides
11/24/2004	EP1479769A1 Method of separately recovering DNA and RNA and kit for recovering nucleic acids
11/24/2004	EP1479766A1 Dna nanocage by self-organization of dna and process for producing the same, and dna nanotube and molecule carrier using the same
11/24/2004	EP1479765A2 Enzymes with xylanase activity from aspergillus aculeatus
11/24/2004	EP1479763A2 Mutant luciferase having increased thermostability
11/24/2004	EP1479762A1 Novel dehydrogenase and gene encoding the same
11/24/2004	EP1479761A1 New enterovirus, vaccines, medicaments and diagnostic kits
11/24/2004	EP1479759A2 System and apparatus for injecting substance into cell
11/24/2004	EP1479697A1 Tick chitinase
11/24/2004	EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004	EP1479695A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa
11/24/2004	EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004	EP1479690A1 Cytokine isolated from an insect
11/24/2004	EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004	EP1479395A1 Modified factor VII
11/24/2004	EP1478784A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
11/24/2004	EP1478781A2 Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
11/24/2004	EP1478779A1 COMPOUNDS AND PROCESSES FOR SINGLE-POT ATTACHMENT OF A LABEL TO siRNA
11/24/2004	EP1478778A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478775A2 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins
11/24/2004	EP1478774A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/24/2004	EP1478770A2 Screening method for orthopoxvirus antivirals
11/24/2004	EP1478769A2 Phytases, nucleic acids encoding them and methods for making and using them
11/24/2004	EP1478764A2 Humanized collagen antibodies and related methods
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478761A1 Degradation of hydrophobic ester pesticides and toxins
11/24/2004	EP1478760A1 Esterases with lipase activity
11/24/2004	EP1478759A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
11/24/2004	EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004	EP1478757A2 Production of dadzein in transgenic plants
11/24/2004	EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004	EP1478755A1 Expression cloning methods in filamentous fungi
11/24/2004	EP1478754A2 Fungal chitinases, polynucleotide sequences encoding same, promoters of same, and uses thereof
11/24/2004	EP1478753A1 Genetic sequences having methyltransferase activity and uses therefor
11/24/2004	EP1478752A2 Human chemokine-13
11/24/2004	EP1478751A2 Avian lysozyme promoter
11/24/2004	EP1478750A2 Gene expression by positive feedback activation of a cell type-specific promoter
11/24/2004	EP1478749A1 Method for coarse purification of cell digests from microorganisms
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478742A2 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity
11/24/2004	EP1478740A2 Heteromultimeric tnf ligand family members
11/24/2004	EP1478738A1 Anti-ccr5 antibody
11/24/2004	EP1478733A2 Cold shock inducible expression and production of heterologous polypeptides
11/24/2004	EP1478730A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478665A2 Organic compounds having anti-angiogenic activity
11/24/2004	EP1478664A1 Tissue specific expression
11/24/2004	EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004	EP1478661A2 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
11/24/2004	EP1478659A2 Biologically active peptides

1 ... 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 ... 4023